ARIA 2008 – the role of antihistamines in allergic rhinitis
Article Sidebar
Main Article Content
Abstract
The author presents therapeutic aspects enclosed in the update of ARIA recommendations. The treatment of allergic rhinitis should consider the severity and duration of the disease, the patient’s preference, likely adherence to recommendations, as well as the efficacy, availability and the cost of medications. Second-generation H1-antihistamines are recommended for the treatment of allergic rhinitis and conjunctivitis in children and adult. First-generation oral H1-antihistamines are not recommended when senond-generation ones are available, due to safety concerns.
Downloads
Article Details
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Bousquet J., Khaltaev M., Cruz A.A. et al.: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy 2008, 63(supl. 86): 8-160.